How we can mitigate the side effects associated with systemic glucocorticoid after allogeneic hematopoietic cell transplantation

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts

(2020) George B. McDonald et al.   ANNALS OF INTERNAL MEDICINE

Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy

(2020) Steven M. Bair et al.   CANCER

Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

(2020) Olaf Penack et al.   Lancet Haematology

Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host Disease

(2020) Chiara Frairia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

(2020) Robert Zeiser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Denosumab vs risedronate in glucocorticoid-induced osteoporosis: final results of a 24-month randomized, double-blind, double-dummy trial

(2019) Kenneth G. Saag et al.   Arthritis & Rheumatology

How I treat refractory chronic graft-versus-host disease

(2019) Stefanie Sarantopoulos et al.   BLOOD

Efficacy and Pharmacoeconomic Impact of Letermovir for CMV Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients

(2019) Shelby Lorraine Merchant et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

An updated review of glucocorticoid-related adverse events in patients with rheumatoid arthritis

(2019) Mariana Luís et al.   Expert Opinion On Drug Safety

Early Prediction of Cardiovascular Risk after Hematopoietic Cell Transplantation: Are We There Yet?

(2019) Eleni Gavriilaki et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Randomized Multicenter Trial of Sirolimus vs. Prednisone as Initial Therapy for Standard Risk Acute GVHD: BMT CTN 1501

(2019) Joseph Pidala et al.   BLOOD

Gastrointestinal Graft-versus-Host Disease Is a Risk Factor for Postengraftment Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients

(2018) Yasuo Mori et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation

(2018) Kasey J. Leger et al.   CANCER

Quantitative characterization of the relationship between levels of extended corticosteroid use and related adverse events in a US population

(2018) J. Bradford Rice et al.   CURRENT MEDICAL RESEARCH AND OPINION

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study

(2018) Kenneth G Saag et al.   Lancet Diabetes & Endocrinology

Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study

(2018) M. Amine Amiche et al.   Archives of Osteoporosis

Bone management in hematologic stem cell transplant recipients

(2018) D. L. Kendler et al.   OSTEOPOROSIS INTERNATIONAL

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

(2017) Kenneth G. Saag et al.   NEW ENGLAND JOURNAL OF MEDICINE

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

(2016) Andrew J. Ullmann et al.   ANNALS OF HEMATOLOGY

Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT

(2016) Zachariah DeFilipp et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease

(2016) Yayoi Matsumura-Kimoto et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT

(2016) S Fuji et al.   BONE MARROW TRANSPLANTATION

Hyperglycemia as a possible risk factor for mold infections—the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation

(2016) S Fuji et al.   BONE MARROW TRANSPLANTATION

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

(2016) Felicia Cosman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis

(2016) U. A. Al-Sari et al.   OSTEOPOROSIS INTERNATIONAL

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

(2015) M. Mielcarek et al.   HAEMATOLOGICA

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

(2015) M. Mielcarek et al.   HAEMATOLOGICA

How we treat chronic graft-versus-host disease

(2014) M. E. D. Flowers et al.   BLOOD

Current issues in chronic graft-versus-host disease

(2014) G. Socie et al.   BLOOD

Steroid myopathy: Some unresolved issues

(2014) M. A. Minetto et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

(2014) Roy F. Chemaly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of exercise therapy on muscle mass and physical functioning in patients undergoing allogeneic hematopoietic stem cell transplantation

(2014) Takahiro Takekiyo et al.   SUPPORTIVE CARE IN CANCER

Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients

(2013) Shinichiro Morishita et al.   SUPPORTIVE CARE IN CANCER

First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

(2012) Paul J. Martin et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Challenges to Preventing Infectious Complications, Decreasing Re-hospitalizations, and Reducing Cost Burden in Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation

(2012) Shigeo Fuji et al.   SEMINARS IN HEMATOLOGY

Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation

(2011) Navneet S. Majhail et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Guidance for the adjustment of FRAX according to the dose of glucocorticoids

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Glucocorticoid-induced hypertension

(2011) Julie E. Goodwin et al.   PEDIATRIC NEPHROLOGY

An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients

(2010) Andrew H. Limper et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

How I treat adenovirus in hematopoietic stem cell transplant recipients

(2010) C. A. Lindemans et al.   BLOOD

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial

(2009) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

The epidemiology of glucocorticoid-associated adverse events

(2009) Allyson K McDonough et al.   CURRENT OPINION IN RHEUMATOLOGY

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes

(2008) M. Mielcarek et al.   BLOOD

Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection

(2008) D. Lilleri et al.   HAEMATOLOGICA

Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation

(2008) Yuki Asano-Mori et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY